Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein shisa-5 (SHISA5, also known as SCOTIN) is a single-pass transmembrane adaptor protein residing in the endoplasmic reticulum membrane[1][3]. It functions mainly as a suppressor of basal autophagy, preventing spontaneous formation of autophagic structures by blocking contact between the phagophore and ER exit sites under normal nutrition conditions[1]. SHISA5 is also involved in cell death pathways, notably acting with p53 to induce apoptosis via a caspase-dependent mechanism[3]. The protein is upregulated in certain disease contexts, including liver disorders such as primary biliary cholangitis, where it correlates with disease activity[2]. In cancer and viral infection models, SHISA5 has been implicated in tumor suppression and viral protein degradation, respectively[4]. No drugs are currently known to specifically target SHISA5, nor are drug-specific safety issues documented.
Not established for drug intervention. In a biological context, suppresses basal autophagy via blockade at the ER exit site and can induce apoptosis in a caspase- and p53-dependent way[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein shisa-5 (SHISA5).